GlassScriptPhysician profile
Ramesh Cherukuri
NPI 1891784807
$4,135.72
in general payments reported to CMS, 2019-2025
38 companies · $196 in 2025
The $196 reported for 2025 was more than what 80% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $397 · 2020: $382 · 2021: $282 · 2022: $548 · 2023: $1,070 · 2024: $1,262 · 2025: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,527.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,527.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $423.31 | 2022-2024 | Ultomiris |
| Abiomed | $358.84 | 2022-2024 | Impella |
| Sumitomo Pharma America, INC. | $340.54 | 2023-2024 | Aptiom |
| Emd Serono, INC. | $278.90 | 2022-2024 | Mavenclad |
| Edwards Lifesciences Corporation | $248.43 | 2021-2024 | Mitris Resilia Mitral Valve, Konect Resilia |
| Zimmer Biomet Holdings, INC. | $234.14 | 2023-2024 | |
| Haemonetics Corporation | $217.52 | 2022-2025 | Teg6s Hemostasis System |
| Medtronic Vascular, INC. | $194.76 | 2019-2020 | |
| Lundbeck LLC | $170.47 | 2019-2024 | Rexulti, Vyepti |
| Baxter Healthcare | $162.11 | 2020-2025 | Floseal |
| Teva Pharmaceuticals USA, INC. | $143.00 | 2019 | |
| Davol INC. | $130.42 | 2020-2022 | |
| Eisai INC. | $111.61 | 2023-2024 | |
| Sunovion Pharmaceuticals INC. | $92.45 | 2019-2020 | |
| Csl Behring | $90.39 | 2020-2023 | Kcentra |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramesh Cherukuri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.